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responsibility of XAbstract A new simple spectrophotometric method was developed for the determination of binary
mixtures without prior separation. The method is based on the generation of ratio spectra of compound
X by using a standard spectrum of compound Y as a divisor. The peak to trough amplitudes between
two selected wavelengths in the ratio spectra are proportional to concentration of X without
interference from Y. The method was demonstrated by determination of two drug combinations.
The ﬁrst consists of the two antihyperlipidemics: atorvastatin calcium (ATV) and ezetimibe (EZE), and
the second comprises the antihypertensives: candesartan cilexetil (CAN) and hydrochlorothiazide
(HCT). For mixture 1, ATV was determined using 10 mg/mL EZE as the divisor to generate the ratio
spectra, and the peak to trough amplitudes between 231 and 276 nm were plotted against ATV
concentration. Similarly, by using 10 mg/mL ATV as divisor, the peak to trough amplitudes between
231 and 276 nm were found proportional to EZE concentration. Calibration curves were linear in the
range 2.5–40 mg/mL for both drugs. For mixture 2, divisor concentration was 7.5 mg/mL for both
drugs. CAN was determined using its peak to trough amplitudes at 251 and 277 nm, while HCT was
estimated using the amplitudes between 251 and 276 nm. The measured amplitudes were linearly
correlated to concentration in the ranges 2.5–50 and 1–30 mg/mL for CAN and HCT, respectively. The
proposed spectrophotometric method was validated and successfully applied for the assay of both drug
combinations in several laboratory-prepared mixtures and commercial tablets.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.ersity. Production and hosting by E
.004
871351; fax: þ20 3 4873273.
(T.S. Belal).
i’an Jiaotong University.1. Introduction
One of the main challenges facing analytical chemists is
the spectrophotometric determination of two or more com-
pounds in the same sample without preliminary separation.
The generation of absorbance ratio spectra has been the basislsevier B.V. All rights reserved.
New spectrophotometric method for determination of binary mixtures 119of several analytical procedures for the simultaneous spectro-
photometric determination of compounds in binary and
ternary mixtures. First, binary mixtures were resolved using
the ratio-spectra derivative method [1,2]. Then, this method
was modiﬁed and extended for the determination of ternary
mixtures. Examples of these modiﬁed versions are the deriva-
tive ratio spectra zero-crossing method [3,4], the double
divisor ratio spectra derivative method [5] and the successive
derivative ratio spectra method [6]. Furthermore, the ratio
spectra were exploited for the development of other mathe-
matical methods for resolution of binary and ternary mixtures
such as the mean centering of ratio spectra method [7] and the
ratio subtraction method [8]. In most of these methods, at
least two mathematical processes (e.g., division followed by
derivative curve generation) are needed in order to get the
measurable amplitude that is correlated to the concentration
of only one compound without interference from the others in
the mixture. Obviously, some methods need more sophisti-
cated mathematical treatment to unambiguously determine
the target compound in presence of interferences [8].
Atorvastatin calcium (ATV), a 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitor, is a lipid
regulating drug used to reduce LDL-cholesterol, apolipopro-
tein B and triglycerides, and to increase HDL-cholesterol in
the treatment of hyperlipidaemias. It is also used for prophy-
laxis of cardiovascular events in patients with multiple risk
factors including diabetes mellitus [9]. Ezetimibe (EZE) is an
inhibitor of intestinal absorption of cholesterol and plant
sterols. It is used to reduce total cholesterol, LDL-cholesterol
and apolipoprotein B in the management of hyperlipidaemias
[9]. The assay of the antihyperlipidemic combination of ATV
and EZE was the subject of several analytical reports. These
reports recommended the use of capillary electrophoresis [10],
high performance thin layer chromatography (HPTLC)
[11–13] and several high performance liquid chromatography
(HPLC) with UV detection methods [14–17]. The simulta-
neous spectrophotometric determination of ATV and EZE
was carried out using the H-point standard additions method
[18], the ratio-spectra derivative method [18], the dual wave-
length method [19,20] and the mean centering of ratio spectra
[20]. Moreover, difference spectrophotometry (DA method)
was applied for the determination of EZE in presence of the
co-existing drug ATV [18].
Candesartan cilexetil (CAN) is an angiotensin II receptor
antagonist. It is used in the management of hypertension and
may also be used in heart failure in patients with impaired left
ventricular systolic function [9]. Hydrochlorothiazide (HCT) is
a moderately potent diuretic. It exerts its effect by reducing the
re-absorption of electrolytes from the renal tubules, thereby
increasing the excretion of sodium and chloride ions, and
consequently of water. HCT is used in the treatment of
hypertension either alone or with other antihypertensives. It
is also used to treat oedema associated with heart failure and
with renal and hepatic disorders [9]. The simultaneous deter-
mination of CAN and HCT in their binary combination was
addressed in several analytical reports. These reports proposed
capillary electrophoresis [21], HPTLC [22–24] and HPLC-UV
detection methods [25,26]. An HPLC coupled with photodiode
array detector method was developed for the simultaneous
analysis of CAN and HCT in human plasma and dosage
forms [27]. On the other hand, spectrophotometric methods
used for the assay of this antihypertensive mixture includedifference spectrophotometry [24], derivative spectrophotome-
try [28,29], the ratio-spectra derivative method [28] and the
Q-absorbance method [30].
In this study, a new ratio spectra peak to peak measurement
method was described for the determination of these two
binary mixtures without prior separation. The method
employs only one step (dividing the mixture spectra by a
standard divisor spectrum), followed by peak to peak
measurement in the produced ratio spectra. The method
eliminates the derivative step, and does not require searching
for zero-crossing points or any sophisticated mathematical or
chemometric treatment of data. The developed method was
validated and successfully applied for the assay of these drug
combinations in their commercial tablets.2. Theoretical background
Consider a mixture of two compounds X and Y. The
absorption spectrum of the mixture – measured in 1 cm path
length – is deﬁned by the equation:
AM ¼ eXCX þ eYCY ð1Þ
where AM is the absorbance of the mixture, eX and eY are the
molar absorptivities of X and Y and CX and CY are the
concentrations of X and Y, respectively. If the absorbance of
the mixture is divided by the absorbance of a standard
solution of X (AbsorbanceAX1 ¼ eX  CX1), the following
equation results:
AM
AX1
¼ CX
CX1
þ AY
AX1
ð2Þ
The ratio CX/CX1 is a constant value which can be
eliminated by taking the difference in absorbance ratio
amplitudes between two wavelengths l1 and l2 (peak to peak
measurement):
AM
AX1
 
l1
 AM
AX1
 
l2
¼ AY
AX1
 
l1
 AY
AX1
 
l2
ð3Þ
Eq. (3) illustrates that the difference amplitude in the
mixture absorbance ratio between two wavelengths l1 and l2
(can be called peak to peak, peak to trough or maximum to
minimum measurement) is equal to the same difference
amplitude for compound Y after canceling the constant
interference due to compound X. In the proposed method,
the concentration of compound Y (CY) is proportional to the
peak to peak amplitudes in its absorbance ratio spectra. A
calibration graph is obtained by recording and storing the
spectra of solutions of different concentrations of pure Y, and
the spectrum of a solution of pure X (the divisor X1). The
stored spectra of the solutions of pure Y are divided by the
standard spectrum of the divisor (X1). In the generated ratio
spectra, the peak to peak amplitudes between the selected
wavelengths l1 and l2 are measured and plotted against CY to
obtain the calibration graph. By using the calibration graph,
the concentration of compound Y in the mixture is determined
after similar treatment for the mixture solution. The concen-
tration of X in the mixture is determined by analogous
procedure.
T.S. Belal et al.1203. Experimental
3.1. Apparatus
Helios a UV–VIS spectrophotometer (Unicam, Cambridge,
UK) connected to a PC equipped with Vision 32 Software was
used. Absorbance measurements were recorded in a pair of
10 mm matched quartz cells. The scan speed was set at
1200 nm/min and the band width was ﬁxed at 2 nm.
3.2. Materials
ATV and CAN were kindly supplied by Pharonia Pharma-
ceuticals Co. (Alexandria, Egypt), HCT was a gift from
Pharco Pharmaceuticals Co. (Alexandria, Egypt) and EZE
was kindly provided by Adwia Pharmaceuticals Co. (Cairo,
Egypt). Methanol and sodium hydroxide used were of analy-
tical grade. Distilled water was used throughout the work.
Atorezas tablets (BN. 1131996) labeled to contain 10 mg EZE
and 10.85 mg ATV are manufactured by Marcyrl Pharmaceu-
tical industries, Egypt. Atacand Pluss tablets (BN. 110276D1)
labeled to contain 16 mg CAN and 12.5 mg HCT are manu-
factured by AstraZeneca, Egypt under license of AstraZeneca,
Sweden. Both pharmaceutical preparations were purchased
from the local market.
3.3. General procedure
For mixture 1, stock solutions of EZE 500 mg/mL and ATV
500 mg/mL were prepared in methanol. Portions of both
solutions were separately diluted with methanol to attain the
concentration ranges speciﬁed in Table 1. The absorption
spectra of the prepared standard solutions were recorded in
the range of 200–340 nm against methanol. For the determi-
nation of ATV, the recorded absorption spectra were divided,Table 1 Regression and analytical parameters for the determ
spectrophotometric method.
Parameter Mixture 1
ATV E
Wavelength (nm) 231 and 276 2
Concentration range (mg/mL) 2.5–40 2
Intercept (a) 0.0048 
Sa
a 0.0515 0
Slope (b) 0.2475 0
Sb
b 0.0022 0
RSD% of the slope (Sb%) 0.89 0
Correlation coefﬁcient (r) 0.9998 0
Sy/x
c 0.0645 0
Fd 12513 1
Signiﬁcance F 3.83 108 2
LODe (mg/mL) 0.69 0
LOQf (mg/mL) 2.08 1
aStandard deviation of the intercept.
bStandard deviation of the slope.
cStandard deviation of residuals.
dVariance ratio, equals the mean of squares due to regression divide
eLimit of detection.
fLimit of quantiﬁcation.wavelength by wavelength, by the spectrum of a standard
solution of EZE 10 mg/mL in methanol. The peak to trough
amplitudes in the obtained ATV ratio spectra between 231 and
276 nm were measured and plotted versus the corresponding
concentration. Similarly, a standard spectrum of ATV 10 mg/mL
was used as a divisor in the determination of EZE and the
peak to trough measurements between 231 and 276 nm were
recorded.
For mixture 2, stock solutions of CAN 500 mg/mL and
HCT 500 mg/mL were prepared in methanol. For the con-
struction of the calibration curves; aliquots of both solutions,
covering the concentration ranges mentioned in Table 1, were
transferred into 2 separate sets of 10 mL volumetric ﬂasks.
The volume in each ﬂask was adjusted to 1 mL with methanol
then diluted to the mark with 0.1 M sodium hydroxide
solution. The absorption spectra of the prepared standard
solutions were recorded in the range of 200–340 nm against
solvent blank. For generation of CAN ratio spectra, a
standard spectrum of HCT 7.5 mg/mL was set as the divisor,
and the peak to trough measurements between 251 and
277 nm were used for construction of the calibration graph.
As for HCT calibration, the absorption spectra were divided
by CAN 7.5 mg/mL standard spectrum then the peak to
trough amplitudes between 251 and 276 nm were measured
and plotted versus the corresponding concentration.
3.4. Assay of commercial tablets
3.4.1. Mixture 1 (ATV–EZE)
Ten Atorezas tablets were weighed, powdered and mixed. An
accurately weighed portion of the powdered tablets equivalent to
25 mg EZE was transferred into a 50 mL volumetric ﬂask and
extracted in 30 mL methanol with the aid of a vortex mixer. The
mixture was completed to volume with the same solvent and
ﬁltered to produce tablets-extract solution containing EZEination of the two drug combinations using the proposed
Mixture 2
ZE CAN HCT
31 and 276 251 and 277 251 and 276
.5–40 2.5–50 1–30
0.0068 0.0113 0.0050
.0172 0.0202 0.0344
.0957 0.1216 0.3540
.0008 0.0007 0.0023
.84 0.58 0.65
.9999 0.9999 0.9999
.0237 0.0268 0.0519
5886 32970 23035
.38 108 5.52 109 1.13 108
.59 0.55 0.32
.80 1.66 0.97
d by the mean of squares about regression (due to residuals).
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New spectrophotometric method for determination of binary mixtures 121500 mg/mL and ATV 540 mg/mL. Portions of the extract were
treated as previously described under general procedure.
3.4.2. Mixture 2 (CAN–HCT)
Ten Atacand Pluss were weighted, ﬁnely powdered and
mixed. A quantity of the powdered tablets equivalent to
25 mg HCT was transferred into a 50 mL volumetric ﬂask
and the aforementioned extraction procedure was followed.
The produced tablets-extract solution is labeled to contain
HCT 500 mg/mL and CAN 640 mg/mL. Aliquots of the
prepared extract were treated as previously described.A
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Fig. 2 (A) Ratio spectra of ATV (7.5, 10, 15, 20, 30, 40 mg/mL).
(B) Ratio spectra of ATV 20 mg/mL and a mixture containing
ATV 20 mg/mL and EZE 20 mg/mL. Divisor used was 10 mg/mL
EZE.4. Results and discussion
4.1. Spectral characteristics and optimization of the
measurements
4.1.1. Mixture 1 (ATV–EZE)
The absorption spectra of ATV and EZE show a strong
overlap which hinders the use of conventional UV spectro-
photometry for their simultaneous determination in a binary
mixture (Fig. 1). To overcome the mutual interference of each
compound in the determination of the other, a simple one-step
correction procedure based on the absorbance ratio spectra
was developed. Regarding method optimization; the effect of
the diluting solvent on the intensity of measurements was
investigated. Aqueous solvents including water, 0.1 M sodium
hydroxide (NaOH) and 0.1 M hydrochloric acid (HCl) were
excluded either due to EZE insolubility or its b-lactam ring
instability [31], and accordingly methanol was used for
dilution. A study was carried out to examine the effect of
divisor concentration on the ratio spectra of ATV and EZE.
When the concentration of divisor is increased or decreased,
the resulting absorbance ratio values proportionally decrease
or increase, respectively; however, the positions of the peaks
and troughs remain unaffected by changing the divisor
concentration. Divisor concentration was tested in the range
of 5–15 mg/mL. A concentration of 10 mg/mL of either ATV or
EZE produced the best results in terms of signal-to-noise ratio,
sensitivity, accuracy and repeatability of measurements.
The ratio spectra of different ATV standards at increasing
concentrations in methanol, obtained by dividing each by the
spectrum of 10 mg/mL EZE in the same solvent are illustrated
in Fig. 2A. The peak to trough amplitudes between 231 andFig. 1 Absorption spectra of ATV 15 mg/mL (– – –), EZE 15 mg/mL
(——) and a mixture of ATV 15 mg/mL and EZE 15 mg/mL (– – – –).276 nm on the generated ratio spectra are proportional to
ATV concentration. Fig. 2B shows the ratio spectra of a
standard solution of ATV and a mixture solution containing
the same concentration of ATV. The difference between the 2
spectra is the constant interference value (the term CX/CX1 in
Eq. (2)). This interference was eliminated in Salinas method [1]
by recording the ﬁrst derivative of the mixture ratio spectrum.
Alternatively, the constant interference can be eliminated by
measurement of the absorbance ratio difference between two
selected wavelengths l1 and l2. Ideally, these selected wave-
lengths should correspond to the peak and the trough in the
ratio spectrum in order to achieve the highest sensitivity.
Fig. 2B shows that the peak to trough amplitude in the
mixture spectrum is equal to that in standard ATV spectrum;
therefore ATV can be quantiﬁed in the mixture without
interference from EZE. For the determination of EZE, an
analogous procedure was followed. Fig. 3A shows the ratio
spectra of different standards of EZE using 10 mg/mL ATV as
divisor. The peak to trough amplitudes between 231 and
276 nm on the produced ratio spectra were measured and
found proportional to EZE concentration. Fig. 3B presents
the ratio spectra of a standard solution of EZE and a mixture
solution containing the same concentration of the drug. It is
evident that the measured peak to trough amplitude in the
mixture spectrum is equal to that in standard EZE spectrum.
4.1.2. Mixture 2 (CAN–HCT)
CAN and HCT mixture is another example where the two drugs
exhibit overlapping spectra as shown in Fig. 4. Therefore, their
Fig. 4 Absorption spectra of CAN 20 mg/mL (– – –), HCT
20 mg/mL (——) and a mixture of CAN 20 mg/mL and HCT
20 mg/mL (– – – –).
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Fig. 5 (A) Ratio spectra of CAN (5, 10, 20, 30, 40, 50 mg/mL).
(B) Ratio spectra of CAN 20 mg/mL and a mixture containing
CAN 20 mg/mL and HCT 20 mg/mL. Divisor used was 7.5 mg/
mL HCT.
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Fig. 3 (A) Ratio spectra of EZE (7.5, 10, 15, 20, 30, 40 mg/mL).
(B) Ratio spectra of EZE 20 mg/mL and a mixture containing EZE
20 mg/mL and ATV 20 mg/mL. Divisor used was 10 mg/mL ATV.
T.S. Belal et al.122spectrophotometric simultaneous determination necessitates the
mathematical treatment of the data so as to resolve such a
mixture. That was fruitfully achieved via the application of the
same principle adopted in mixture 1. Concerning the choice of
the diluting solvent; water and 0.1 M HCl were excluded due to
CAN insolubility. 0.1 M NaOH was favored over methanol as
the former exhibited higher absorptivities, in addition to, more
precise and accurate measurements. The divisor concentration
was also studied in the range of 5–15 mg/mL and optimized at
7.5 mg/mL for both drugs.
The ratio spectra obtained from the division of CAN
absorption spectra by a standard spectrum of HCT showeda peak at 251 nm and a trough at 277 nm (Fig. 5A). The peak
to trough measurements between 251 and 277 nm were used
for the construction of CAN calibration equation. Fig. 5B
shows that the peak to trough amplitudes for a standard CAN
and a parallel mixture are identical; therefore CAN can be
quantiﬁed in the mixture without interference from the co-
existing drug HCT. Similarly by using CAN as the divisor, the
peak to trough amplitudes at 251–276 nm were selected for
HCT determination (Fig. 6A). Fig. 6B shows the ratio spectra
of a standard solution of HCT and a mixture solution
containing the same concentration of the drug. Obviously,
the measured peak to trough amplitude in the mixture ratio
spectrum is equal to that of the standard.
4.2. Validation of the proposed spectrophotometric method
4.2.1. Linearity and ranges
The linearity of the proposed method was evaluated through
the analysis of six serial concentrations of each drug.
The produced response was plotted as a function of the
corresponding concentration and the calibration equation
was calculated using the least squares regression method.
Table 1 summarizes the regression and statistical parameters
of the studied drugs. As seen, the regression analysis veriﬁes
the good linearity of the method as indicated by the close to
unity correlation coefﬁcient (r) values. Moreover, the low
values of the standard deviation of the intercept (Sa), standard
deviation of the slope (Sb) and standard deviation of the
residuals (Sy/x) suggest the good linearity of the developed
method and the negligible scatter of the points around the
New spectrophotometric method for determination of binary mixtures 123ﬁtted regression lines. Additionally, the linearity could be
appraised through the calculation of the RSD% of the slope
(Sb%) as the values obtained were less than 1%. The analysis
of variance test for the regression lines reveals that, for equalTable 2 Precision and accuracy for the determination of the fo
method.
Analyte Nominal value (mg/mL) Within-day
Found7SDa (mg/mL) RSD(
ATV 7.5 7.5170.04 0.53
15 14.9970.05 0.33
30 29.9770.17 0.57
EZE 7.5 7.4570.08 1.07
15 14.9370.14 0.94
30 30.0370.03 0.10
CAN 10 9.9570.04 0.40
20 19.9170.15 0.75
40 40.0470.10 0.25
HCT 7.5 7.5270.07 0.93
15 14.8570.10 0.67
30 29.9970.10 0.33
aMean7standard deviation for three determinations.
b% relative standard deviation.
c% relative error.
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Fig. 6 (A) Ratio spectra of HCT (2.5, 5, 10, 15, 20, 30 mg/mL).
(B) Ratio spectra of HCT 20 mg/mL and a mixture containing
HCT 20 mg/mL and CAN 20 mg/mL, Divisor used was 7.5 mg/mL
CAN.degrees of freedom, an increase in the variance ratio (F values)
means an increase in the mean of squares due to regression
and a decrease in the mean of squares due to residuals. The
greater the mean of squares is due to regression, the steeper
the regression line is. The smaller the mean of squares is due to
residuals, the less the scatter of experimental points around the
regression line is. Consequently, regression lines with high F
values (low signiﬁcance F) are much better than those with
lower ones. Good regression lines show high values for both r
and F statistical parameters [32].
4.2.2. Limits of detection and quantiﬁcation
Limits of detection (LOD) and quantiﬁcation (LOQ) were
calculated according to the ICH guidelines [33]. LOD was
deﬁned as 3.3Sa/b and LOQ was computed as 10Sa/b, where
Sa is the standard deviation of the intercept and b is the slope
of the calibration curve. The sensitivity of the proposed
method can be conﬁrmed by the low LOD and LOQ values
obtained (Table 1).
4.2.3. Precision and accuracy
According to the ICH guidelines [33], the within-day repeat-
ability of the proposed method was assessed through the
analysis of 3 concentration levels prepared in triplicates.
Correspondingly, the between-day precision was studied on
the same levels over 3 consecutive days. Table 2 contains the
values of percentage relative standard deviation (RSD%)
which did not exceed 1.7% for both mixtures indicating the
acceptable level of precision of the proposed method. The
adequate recovered concentrations in addition to the low
values of percentage relative error (Er%) gathered in Table 2
also conﬁrm the accuracy of the developed method.
4.2.4. Stability of solutions
Stock solutions of the studied drugs were found stable at 4 1C
for a period of not less than 2 weeks. Also, stability of theur drugs in bulk form using the proposed spectrophotometric
Between-day
%)b Er(%)
c Found7SDa (mg/mL) RSD (%)b Er(%)
c
0.13 7.4470.05 0.67 0.80
0.07 15.0470.17 1.13 0.27
0.10 30.0570.22 0.73 0.17
0.67 7.4970.09 1.20 0.13
0.47 14.9470.15 1.00 0.40
0.10 30.0070.28 0.93 0.00
0.50 9.9270.10 1.01 0.80
0.45 20.0770.29 1.45 0.35
0.10 40.2370.46 1.14 0.58
0.27 7.4570.12 1.61 0.67
1.00 15.0270.15 1.00 0.13
0.03 29.9270.14 0.47 0.27
T.S. Belal et al.124prepared standard solutions in methanol (for Mixture 1) and
in 0.1 M NaOH (for Mixture 2) was veriﬁed by keeping them
at room temperature for 4 h, and no signiﬁcant spectrophoto-
metric changes were noticed.4.3. Applications of the proposed method
4.3.1. Analysis of laboratory-prepared synthetic mixtures
In order to further assess the applicability of the proposed
method for the determination of the selected drugs in their
binary solutions, synthetic mixtures were prepared. These
mixtures contained different ratios of each drug pair; both
above and below their normal ratios in tablets. The acceptableTable 3 Determination of ATV-EZE laboratory-prepared mixtu
Nominal value (mg/mL) Found7SDa (mg/mL)
ATV EZE ATV EZE
10 30 10.1270.16 29.977
20 40 20.2070.21 39.387
20 20 19.9670.30 20.007
40 20 40.0470.11 19.817
40 10 39.9970.25 10.017
aMean7standard deviation for ﬁve determinations.
b% relative standard deviation.
c% relative error.
Table 4 Determination of CAN-HCT laboratory-prepared mixt
Nominal value (mg/mL) Found7SDa (mg/mL)
CAN HCT CAN HCT
40 10 39.7270.06 10.077
40 20 39.9870.29 19.907
20 20 20.0270.14 20.027
10 20 10.0270.18 19.947
10 30 10.0470.18 29.777
aMean7standard deviation for ﬁve determinations.
b% relative standard deviation.
c% relative error.
Table 5 Analysis of ATV–EZE mixture in Atorezas tablets and
spectrophotometric method and the reference method.
Parameter ATV–EZE (Atorezas)
Proposed method Reference method
ATV EZE ATV EZE
%Recovery7SDa 100.1170.53 99.3870.42 100.1770.63 99.23
RSD (%)b 0.53 0.42 0.63 0.61
t 0.19 0.47
F 1.41 2.05
Theoretical values for t and F at P¼0.05 are 2.31 and 6.39, respective
aMean7standard deviation for ﬁve determinations.
b% relative standard deviation.recovered concentrations, values of RSD(%) and Er(%)
compiled in Tables 3 and 4 for ATV–EZE and CAN–HCT
mixtures, respectively, conﬁrm the accuracy and precision of
the method, and demonstrate its analytical power to resolve
and quantify the investigated drugs when present in different
proportions.4.3.2. Analysis of commercial tablets
The proposed method was successfully applied to the analysis
of both mixtures in their pharmaceutical preparations. Results
obtained were precise and in good agreement with the labeled
claim as concluded from the satisfactory values of % recovery
and RSD(%) gathered in Table 5. An HPLC-UV [15] and anres using the proposed spectrophotometric method.
RSD(%)b Er(%)
c
ATV EZE ATV EZE
0.15 1.58 0.50 1.20 0.10
0.45 1.04 1.14 1.00 1.55
0.18 1.50 0.90 0.20 0.00
0.10 0.28 0.51 0.10 -0.95
0.04 0.63 0.40 0.02 0.10
ures using the proposed spectrophotometric method.
RSD(%)b Er(%)
c
CAN HCT CAN HCT
0.17 0.15 1.69 0.70 0.70
0.26 0.73 1.31 0.05 -0.50
0.09 0.70 0.45 0.10 0.10
0.28 1.80 1.40 0.20 0.30
0.21 1.79 0.71 0.40 0.77
CAN–HCT mixture in Atacand Pluss tablets by the proposed
CAN–HCT (Atacand Pluss)
Proposed method Reference method
CAN HCT CAN HCT
70.60 99.8771.19 99.6570.74 99.9671.11 99.6270.54
1.19 0.74 1.11 0.55
0.12 0.07
1.15 1.88
ly.
Table 6 Application of standard addition technique for analysis of ATV–EZE mixture in Atorezas tablets and CAN–HCT
mixture in Atacand Pluss tablets.
Tablets Mixture Recovery(%)7SDa RSD (%)b
Atorezas tablets ATV 100.2670.68 0.68
EZE 99.6371.00 1.00
Atacand pluss tablets CAN 99.7870.66 0.66
HCT 99.6470.55 0.55
aMean7standard deviation for ﬁve determinations.
b% relative standard deviation.
New spectrophotometric method for determination of binary mixtures 125HPLC-DAD [27] reference methods were applied to the
analysis of Atorezas and Atacand Pluss tablets extract
solutions, respectively. Statistical comparison of the results
was achieved through Student’s t-test for accuracy and
variance ratio F-test for precision and revealed no signiﬁcant
differences between the proposed and reference HPLC meth-
ods at the 95% conﬁdence level (Table 5). Furthermore,
standard addition technique was also applied by adding the
pure drugs to aliquots of the tablets extracts, and recovery of
each drug was then calculated by comparing the drug response
with the increment response attained after addition of the
standard. Recoveries and RSD(%) values obtained by appli-
cation of the standard addition technique are shown in
Table 6. The good recoveries obtained using both external
standard and standard addition methods (Tables 5 and 6)
suggest that there was no interference from the co-formulated
inactive ingredients. It is evident from these results that the
proposed method is applicable to the assay of both drug
combinations with minimum sample preparation and satisfac-
tory levels of accuracy and precision.4.4. Comparison with other spectrophotometric methods
The new spectrophotometric method is adequate for the
routine quality control analysis of the cited compounds in
their commercial preparations. It could be also extended to the
analysis of other ﬁxed-dose combination products containing
drugs with interfering spectra. In addition, it is advantageous
over other spectrophotometric techniques employing mathe-
matical transformation of the absorption data for binary
mixture resolution. In this simple method, one compound
could be determined through the peak to peak or peak to
trough measurements at two selected wavelengths in this
compound ratio spectra. Via this approach, the interference
due to the other coexisting compound is converted into a
constant through division and subsequently deleted through
subtraction.
Compared to derivative spectrophotometry, this method
avoids searching for the appropriate wavelength in the
derivative spectrum of the compound under analysis corre-
sponding to a zero-crossing point for the interfering com-
pound. Some binary mixtures require the use of higher
derivative orders (3rd or 4th) to ﬁnd suitable points for
determination of one compound without interference from
the other. Unlike derivative ratio, the proposed method lacks
the additional step of the derivative curve generation. It is also
much simpler than the ratio subtraction method as it does not
include the sequential order of manipulations viz. division,constant subtraction and multiplication. Moreover, it can be
used for the quantiﬁcation of both drugs concurrently rather
than the need for an additional method for the extended
component. Difference spectrophotometry (DA method)
seems to be a simple technique for analysis of one compound
in presence of another based on the zero order spectra;
however, it requires the preparation of each sample in
two different solvent media; a time, chemicals and solvents
consuming problem that is absent in the current method.
Finally, the proposed method does not include the tedious
search for two wavelengths where the interfering compound
shows the same absorptivity as in dual wavelength method.5. Conclusion
A novel, simple, rapid and sensitive method is proposed for the
analysis of two binary mixtures with overlapping spectra. The
method involves the generation of absorbance ratio spectra
followed by measurement of the peak to trough amplitudes.
The proposed method does not require any sophisticated
mathematical treatment for the absorption data, and it exhibits
several advantages over other spectrophotometric methods for
resolution of binary mixtures. ATV and EZE in the ﬁrst mixture
as well as CAN and HCT in the second one were well resolved
and quantiﬁed without prior separation through simple mathe-
matical treatment. The applicability of the developed method
was evaluated through the determination of both drug combina-
tions in several laboratory-prepared mixtures and in pharmaceu-
tical tablets with good accuracy and precision. Therefore, the
presented methodology is adequate for the routine quality
control analysis of these ﬁxed-dose combinations.
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